Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 148-reexam: Non-Final Action Mailed on 12-21-2007

149 expires in 2 years so most of the income will be for prior infringement anyway.

see page inn Pohl's presentation of patent expiry.

also good stuff for Newbies

http://www.ptsc.com/documentation/PT...

Share
New Message
Please login to post a reply